Strongbridge (NASDAQ: SBBP) stock has already increased by 14% and may not stop there. April 29 is the last time when it was on top, it cost $2.65. Since May 21, it is still soaring. Now, $2.83 becomes real for visionary speculators.
On Monday, it became known that Xeris Pharmaceuticals (XERS) is purchasing Strongbridge Biopharma with stock and contingent value rights for $267 million. Xeris shareholders will own 60%, while Strongbridge shareholders will own approximately 40$. The deal will be closed in the fourth quarter of 2021, and the combined company will be named Xeris Biopharma Holdings.
This deal is very effective because it will a scalable biopharmaceutical company focused on products with rare diseases. This will provide commercial success and development products for long period.
Editor in Chief.
Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life